MI-CP079 Phase II Randomized Double-Blind Multicenter Trial of Subcutaneous Amifostine (Ethyol) Versus Placebo in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients with Unresctable Non-Small Cell Lung Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/049/30/06

Funding

  • MedImmune Inc: $2,500.00